SPATA6

gene
On this page

Also known as SRF1FLJ10007SRF-1

Summary

SPATA6 (spermatogenesis associated 6, HGNC:18309) is a protein-coding gene on chromosome 1p33, encoding Spermatogenesis-associated protein 6 (Q9NWH7). Required for formation of the sperm connecting piece during spermiogenesis.

Predicted to enable myosin light chain binding activity. Predicted to be involved in motile cilium assembly and spermatogenesis. Predicted to be located in extracellular region and motile cilium. Predicted to be active in sperm head-tail coupling apparatus.

Source: NCBI Gene 54558 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 90 total
  • MANE Select transcript: NM_019073

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18309
Approved symbolSPATA6
Namespermatogenesis associated 6
Location1p33
Locus typegene with protein product
StatusApproved
AliasesSRF1, FLJ10007, SRF-1
Ensembl geneENSG00000132122
Ensembl biotypeprotein_coding
OMIM613947
Entrez54558

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 11 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay

ENST00000371841, ENST00000371843, ENST00000371847, ENST00000396199, ENST00000463938, ENST00000465990, ENST00000471975, ENST00000487543, ENST00000487629, ENST00000490850, ENST00000603831, ENST00000872885, ENST00000872886, ENST00000872887, ENST00000872888, ENST00000930127, ENST00000930128, ENST00000930129

RefSeq mRNA: 3 — MANE Select: NM_019073 NM_001286238, NM_001286239, NM_019073

CCDS: CCDS551, CCDS65535, CCDS72787

Canonical transcript exons

ENST00000371847 — 13 exons

ExonStartEnd
ENSE000014563094847195848472204
ENSE000018798644829537348298893
ENSE000034692344830578748305878
ENSE000034757824841146448411588
ENSE000035299784835958648359770
ENSE000035398294839935148399644
ENSE000035496104838530948385349
ENSE000035540994835567048355769
ENSE000036721334839526748395354
ENSE000036735884845155248451600
ENSE000036773924840380248403882
ENSE000036905974841311048413151
ENSE000037422614845299448453131

Expression profiles

Bgee: expression breadth ubiquitous, 239 present calls, max score 99.65.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.6425 / max 297.7161, expressed in 1520 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
122568.83271491
122520.9732479
122530.4248231
122550.201977
122540.169082
122490.03345
122480.00743

Top tissues by expression

281 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001999.65gold quality
male germ cellCL:000001598.27gold quality
left testisUBERON:000453397.76gold quality
right testisUBERON:000453497.32gold quality
sural nerveUBERON:001548895.30gold quality
testisUBERON:000047395.29gold quality
adult organismUBERON:000702395.23gold quality
bronchial epithelial cellCL:000232892.13gold quality
calcaneal tendonUBERON:000370191.98gold quality
mucosa of paranasal sinusUBERON:000503090.45gold quality
right uterine tubeUBERON:000130288.13gold quality
epithelium of bronchusUBERON:000203186.99gold quality
tendonUBERON:000004386.81gold quality
tibial nerveUBERON:000132386.45gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.98gold quality
bronchusUBERON:000218585.97gold quality
olfactory segment of nasal mucosaUBERON:000538685.97gold quality
left ovaryUBERON:000211983.57gold quality
colonic epitheliumUBERON:000039783.17gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.15gold quality
right adrenal gland cortexUBERON:003582782.80gold quality
caput epididymisUBERON:000435882.33gold quality
adrenal tissueUBERON:001830382.02gold quality
corpus callosumUBERON:000233681.84gold quality
tibiaUBERON:000097981.65gold quality
right adrenal glandUBERON:000123381.49gold quality
right ovaryUBERON:000211881.49gold quality
epithelium of nasopharynxUBERON:000195181.37gold quality
left adrenal gland cortexUBERON:003582581.34gold quality
left adrenal glandUBERON:000123481.30gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-134144yes31.51
E-ANND-3yes12.40

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

174 targeting SPATA6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3163100.0077.238605
HSA-MIR-3134100.0066.43777
HSA-MIR-126-5P100.0072.713180
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-186-5P99.9970.833707
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-1213699.9872.815713
HSA-MIR-548N99.9871.944170
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-314899.9775.066478
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-9-3P99.9670.882068
HSA-MIR-570-3P99.9672.414910
HSA-LET-7C-3P99.9573.422862
HSA-MIR-548AB99.9571.313488
HSA-MIR-55999.9572.283609

Literature-anchored findings (GeneRIF, showing 3)

  • SPATA6 may play an important role in testicular germ cell tumors, and down-regulation of SPATA6 could lead to apoptosis of testicular germ cell tumors. (PMID:26464655)
  • Increased DNA methylation in the spermatogenesis-associated (SPATA) genes correlates with infertility. (PMID:31838782)
  • Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans. (PMID:36415156)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusSpata6ENSMUSG00000034401
rattus_norvegicusSpata6ENSRNOG00000007568
drosophila_melanogasterCG14079FBGN0036849

Paralogs (1): SPATA6L (ENSG00000106686)

Protein

Protein identifiers

Spermatogenesis-associated protein 6Q9NWH7 (reviewed: Q9NWH7)

All UniProt accessions (6): Q9NWH7, A0A140VJV1, A8MU33, B1AN51, S4R3R3, S4R3X9

UniProt curated annotations — full annotation on UniProt →

Function. Required for formation of the sperm connecting piece during spermiogenesis. Sperm connecting piece is essential for linking the developing flagellum to the head during late spermiogenesis. May be involved in myosin-based microfilament transport through interaction with myosin subunits.

Subunit / interactions. Interacts with MYL6.

Subcellular location. Secreted. Cell projection. Cilium. Flagellum.

Similarity. Belongs to the SPATA6 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9NWH7-11yes
Q9NWH7-22

RefSeq proteins (3): NP_001273167, NP_001273168, NP_061946* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR032732SPATA6_NDomain
IPR042769SPATA6_famFamily

Pfam: PF14909

UniProt features (24 total): modified residue 11, sequence variant 4, region of interest 2, sequence conflict 2, signal peptide 1, chain 1, glycosylation site 1, cross-link 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NWH7-F165.120.23

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (12): 346, 354, 424, 465, 487, 248, 217, 219, 265, 274, 325, 343

Glycosylation sites (1): 181

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 202 (showing top): AP2_Q3, GOBP_MALE_GAMETE_GENERATION, CAGCTG_AP4_Q5, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GNF2_CCNA1, PU1_Q6, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, RGAGGAARY_PU1_Q6, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, AP2_Q6_01, AP2GAMMA_01

GO Biological Process (3): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), motile cilium assembly (GO:0044458)

GO Molecular Function (2): myosin light chain binding (GO:0032027), protein binding (GO:0005515)

GO Cellular Component (5): extracellular region (GO:0005576), motile cilium (GO:0031514), sperm head-tail coupling apparatus (GO:0120212), cilium (GO:0005929), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
developmental process involved in reproduction1
male gamete generation1
cellular developmental process1
cilium assembly1
myosin binding1
binding1
cilium1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1

Protein interactions and networks

STRING

664 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SPATA6SUN5Q8TC36749
SPATA6SWI5Q1ZZU3717
SPATA6ODF1Q14990707
SPATA6OAZ3Q9UMX2678
SPATA6PMFBP1Q8TBY8656
SPATA6MEGF10Q96KG7631
SPATA6TSSK4Q6SA08607
SPATA6SPATA20Q8TB22595
SPATA6SPATC1LQ9H0A9594
SPATA6HOOK1Q9UJC3587
SPATA6SCARF1Q14162576
SPATA6SPATA18Q8TC71563
SPATA6DNAH1Q9P2D7561
SPATA6ROPN1Q9HAT0552
SPATA6CABYRO75952526

IntAct

4 interactions, top by confidence:

ABTypeScore
SPATA6DDB2psi-mi:“MI:0915”(physical association)0.500
SPATA6SNX17psi-mi:“MI:0914”(association)0.350
FTLpsi-mi:“MI:0914”(association)0.350

BioGRID (17): SPATA6 (Affinity Capture-MS), NEDD8-MDP1 (Affinity Capture-MS), DDB2 (Affinity Capture-MS), SPATA6 (Affinity Capture-RNA), SPATA6 (Affinity Capture-MS), SPATA6 (Synthetic Lethality), SPATA6 (Two-hybrid), SPATA6 (Two-hybrid), SPATA6 (Two-hybrid), GEM (Two-hybrid), SPATA6 (Affinity Capture-RNA), C2orf44 (Affinity Capture-MS), IP6K1 (Affinity Capture-MS), WDR83 (Affinity Capture-MS), SNX17 (Affinity Capture-MS)

ESM2 similar proteins: A0JNF3, A3KMW7, A6NFA0, B2RQL2, B2RV46, D3Z8E6, D3ZAP3, D3ZJ47, E9Q309, E9Q793, F5H4B4, O14513, O60303, Q0P5X5, Q1RMQ5, Q2KIP3, Q2KJG1, Q2T9M9, Q32LN6, Q3URK1, Q3V0J4, Q3V0M2, Q53FD0, Q5PQL8, Q5T5Y3, Q642A3, Q68FV5, Q6AYJ3, Q6AYP4, Q6ZVD7, Q7PCK7, Q8BJS7, Q8CB14, Q8CCC3, Q8CCG1, Q8CDL9, Q8K3V1, Q8K3V7, Q8N4H0, Q95LL2

Diamond homologs: B2RV46, Q2KJG1, Q3U6K5, Q6AYJ3, Q8N4H0, Q99MU5, Q9NWH7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

90 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance78
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3179 predictions. Top by Δscore:

VariantEffectΔscore
1:48307216:T:TAdonor_gain1.0000
1:48403782:TTTA:Tdonor_gain1.0000
1:48403783:TTAT:Tdonor_gain1.0000
1:48403828:T:Cdonor_gain1.0000
1:48411462:A:ACdonor_gain1.0000
1:48411463:C:CCdonor_gain1.0000
1:48411463:CT:Cdonor_gain1.0000
1:48411585:CCCA:Cacceptor_gain1.0000
1:48411586:CCAC:Cacceptor_gain1.0000
1:48411589:C:CCacceptor_gain1.0000
1:48451551:CATT:Cdonor_gain1.0000
1:48452989:CTCA:Cdonor_loss1.0000
1:48452990:TCA:Tdonor_loss1.0000
1:48452991:CA:Cdonor_loss1.0000
1:48452992:A:ACdonor_gain1.0000
1:48452992:ACCTT:Adonor_loss1.0000
1:48452993:C:CCdonor_gain1.0000
1:48453127:GTTAC:Gacceptor_gain1.0000
1:48453128:TTAC:Tacceptor_gain1.0000
1:48453129:TAC:Tacceptor_gain1.0000
1:48453129:TACC:Tacceptor_loss1.0000
1:48453130:AC:Aacceptor_gain1.0000
1:48453131:CC:Cacceptor_gain1.0000
1:48453132:C:CCacceptor_gain1.0000
1:48471956:A:ACdonor_gain1.0000
1:48471957:C:CCdonor_gain1.0000
1:48471957:CTGAG:Cdonor_gain1.0000
1:48305781:TCATA:Tdonor_loss0.9900
1:48305782:CATA:Cdonor_loss0.9900
1:48305783:ATAC:Adonor_loss0.9900

AlphaMissense

3200 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:48403860:A:GF143S1.000
1:48355719:C:GR382P0.999
1:48403859:A:CF143L0.999
1:48403859:A:TF143L0.999
1:48403861:A:GF143L0.999
1:48411546:A:GF108S0.999
1:48413130:A:GL87S0.999
1:48453000:A:CF61L0.999
1:48453000:A:TF61L0.999
1:48453001:A:GF61S0.999
1:48453002:A:GF61L0.999
1:48399363:A:CF256L0.998
1:48399363:A:TF256L0.998
1:48399365:A:GF256L0.998
1:48411539:A:CF110L0.998
1:48411539:A:TF110L0.998
1:48411541:A:GF110L0.998
1:48451557:A:GL78P0.998
1:48453019:A:GF55S0.998
1:48453085:A:GL33P0.998
1:48399390:G:CF247L0.997
1:48399390:G:TF247L0.997
1:48399392:A:GF247L0.997
1:48399454:A:GM226T0.997
1:48399457:C:GR225P0.997
1:48399459:T:AR224S0.997
1:48399459:T:GR224S0.997
1:48403842:A:CI149S0.997
1:48403866:A:GL141P0.997
1:48411552:C:GR106P0.997

dbSNP variants (sampled 300 via entrez): RS1000004079 (1:48286037 C>T), RS1000035303 (1:48286351 T>A), RS1000038163 (1:48368956 G>T), RS1000038505 (1:48440758 A>T), RS1000041328 (1:48360200 G>GA), RS1000044276 (1:48397219 G>A), RS1000050794 (1:48324960 A>G), RS1000105000 (1:48422794 G>A), RS1000106072 (1:48369083 A>T), RS1000111233 (1:48378319 A>G), RS1000111746 (1:48331755 C>T), RS1000115638 (1:48314200 A>C,T), RS1000130964 (1:48394270 A>G), RS1000137398 (1:48300313 G>A,C), RS1000158053 (1:48469670 T>A,C)

Disease associations

OMIM: gene MIM:613947 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST008753_1Early spontaneous preterm birth4.000000e-07
GCST009391_1153Metabolite levels3.000000e-07
GCST009391_772Metabolite levels5.000000e-06

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0006917spontaneous preterm birth
EFO:0010459aminoadipic acid measurement
EFO:0010393sphingomyelin 18:0 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, increases expression3
sodium arsenitedecreases expression, affects cotreatment, increases abundance2
Nickeldecreases expression2
Cadmium Chloridedecreases expression2
aristolochic acid Idecreases expression1
FR900359increases phosphorylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
trichostatin Adecreases expression1
arseniteincreases methylation1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
Sunitinibdecreases expression1
Arsenic Trioxidedecreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Manganeseaffects cotreatment, decreases expression, increases abundance1
Phthalic Acidsincreases methylation1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1decreases methylation1
Asbestos, Crocidolitedecreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.